SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001854270-24-000054
Filing Date
2024-05-09
Accepted
2024-05-09 16:19:15
Documents
2
Period of Report
2024-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1715285942.html 3  
1 FORM 3 wk-form3_1715285942.xml 3 1689
2 EX-24 liyvonnepoa.txt EX-24 4590
  Complete submission text file 0001854270-24-000054.txt   7984
Mailing Address C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address
Li Yvonne (Reporting) CIK: 0001735045 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40440 | Film No.: 24931001

Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Issuer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)